South Korea Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2026-2034
The South Korea cell therapy market size reached USD 342.2 Million in 2025. Looking forward, the market is expected to reach USD 1,184.1 Million by 2034, exhibiting a growth rate (CAGR) of 14.35 % during 2026-2034. The market is driven by increasing government support for regenerative medicine, rising prevalence of chronic diseases, and strong R&D investments. Expansion of cell manufacturing infrastructure and growing clinical trial activity further influence South Korea cell therapy market share.
SOUTH KOREA CELL THERAPY MARKET TRENDS:
Accelerating Clinical Trials and Regulatory Support
South Korea has streamlined regulatory pathways for cell therapy, enabling faster clinical trial approvals and market entry. National initiatives provide funding for regenerative medicine research, supporting both academic institutions and private enterprises. Public-private collaborations have enabled the expansion of trial sites and the acceleration of phase II and III trials targeting oncology, autoimmune, and neurodegenerative diseases. These initiatives facilitate access to novel therapies and attract global partnerships. As the ecosystem matures, the availability of patient populations and well-established clinical infrastructure further attract international investments. This strengthened regulatory and trial landscape underpins South Korea cell therapy market growth. For instance, in June 2025, South Korean researchers at KAIST have pioneered a groundbreaking, non?toxic approach to cancer treatment. Using an AI-driven tool called BENEIN (Boolean Network Inference), they identified three key genes—MYB, HDAC2, and FOXA2—that sustain malignant behavior in colorectal cancer cells. By silencing these genes simultaneously, tumor cells reverted to normal-like enterocytes in lab cultures and mice, shrinking tumors without chemotherapy or radiation. This work, published in Advanced Science, may mark a major step toward universal, side-effect?free cancer therapies.
Technological Advancements in Cell Manufacturing
South Korean manufacturers are advancing scalable, GMP-compliant production pipelines for cell-based therapies. Innovations in allogeneic and autologous cell processing, automated bioreactors, and cryopreservation techniques are improving product consistency and reducing costs. Integration of AI-driven analytics optimizes cell quality, yield, and phenotype characterization. These technological advancements promote standardization and facilitate commercial-scale rollouts. Moreover, strategic partnerships between biotech firms and contract development and manufacturing organizations (CDMOs) enhance supply chain resilience. These improvements in manufacturing infrastructure and capabilities represent a key driver of South Korea cell therapy market growth. For instance, in August 2024, SK pharmteco and Rznomics signed an MOU for a multi-year partnership to co-develop and manufacture RNA-based gene therapies. SK pharmteco will support Rznomics with technical expertise and manufacturing capacity to advance products like RZ-001, targeting cancers and neurodegenerative diseases. The collaboration aims to move therapies into late-stage clinical trials and commercialization.
SOUTH KOREA CELL THERAPY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on cell type, therapy type, therapeutic area, and end user.
Cell Type Insights:
Therapy Type Insights:
Therapeutic Area Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea cell therapy market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea cell therapy market on the basis of cell type?
What is the breakup of the South Korea cell therapy market on the basis of therapy type?
What is the breakup of the South Korea cell therapy market on the basis of therapeutic area?
What is the breakup of the South Korea cell therapy market on the basis of end user?
What is the breakup of the South Korea cell therapy market on the basis of region?
What are the various stages in the value chain of the South Korea cell therapy market?
What are the key driving factors and challenges in the South Korea cell therapy market?
What is the structure of the South Korea cell therapy market and who are the key players?
What is the degree of competition in the South Korea cell therapy market?
SOUTH KOREA CELL THERAPY MARKET TRENDS:
Accelerating Clinical Trials and Regulatory Support
South Korea has streamlined regulatory pathways for cell therapy, enabling faster clinical trial approvals and market entry. National initiatives provide funding for regenerative medicine research, supporting both academic institutions and private enterprises. Public-private collaborations have enabled the expansion of trial sites and the acceleration of phase II and III trials targeting oncology, autoimmune, and neurodegenerative diseases. These initiatives facilitate access to novel therapies and attract global partnerships. As the ecosystem matures, the availability of patient populations and well-established clinical infrastructure further attract international investments. This strengthened regulatory and trial landscape underpins South Korea cell therapy market growth. For instance, in June 2025, South Korean researchers at KAIST have pioneered a groundbreaking, non?toxic approach to cancer treatment. Using an AI-driven tool called BENEIN (Boolean Network Inference), they identified three key genes—MYB, HDAC2, and FOXA2—that sustain malignant behavior in colorectal cancer cells. By silencing these genes simultaneously, tumor cells reverted to normal-like enterocytes in lab cultures and mice, shrinking tumors without chemotherapy or radiation. This work, published in Advanced Science, may mark a major step toward universal, side-effect?free cancer therapies.
Technological Advancements in Cell Manufacturing
South Korean manufacturers are advancing scalable, GMP-compliant production pipelines for cell-based therapies. Innovations in allogeneic and autologous cell processing, automated bioreactors, and cryopreservation techniques are improving product consistency and reducing costs. Integration of AI-driven analytics optimizes cell quality, yield, and phenotype characterization. These technological advancements promote standardization and facilitate commercial-scale rollouts. Moreover, strategic partnerships between biotech firms and contract development and manufacturing organizations (CDMOs) enhance supply chain resilience. These improvements in manufacturing infrastructure and capabilities represent a key driver of South Korea cell therapy market growth. For instance, in August 2024, SK pharmteco and Rznomics signed an MOU for a multi-year partnership to co-develop and manufacture RNA-based gene therapies. SK pharmteco will support Rznomics with technical expertise and manufacturing capacity to advance products like RZ-001, targeting cancers and neurodegenerative diseases. The collaboration aims to move therapies into late-stage clinical trials and commercialization.
SOUTH KOREA CELL THERAPY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on cell type, therapy type, therapeutic area, and end user.
Cell Type Insights:
- Stem Cell
- Bone Marrow
- Blood
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Others
- Non-stem Cell
Therapy Type Insights:
- Autologous
- Allogeneic
Therapeutic Area Insights:
- Malignancies
- Musculoskeletal Disorders
- Autoimmune Disorders
- Dermatology
End User Insights:
- Hospitals and Clinics
- Academic and Research Institutes
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea cell therapy market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea cell therapy market on the basis of cell type?
What is the breakup of the South Korea cell therapy market on the basis of therapy type?
What is the breakup of the South Korea cell therapy market on the basis of therapeutic area?
What is the breakup of the South Korea cell therapy market on the basis of end user?
What is the breakup of the South Korea cell therapy market on the basis of region?
What are the various stages in the value chain of the South Korea cell therapy market?
What are the key driving factors and challenges in the South Korea cell therapy market?
What is the structure of the South Korea cell therapy market and who are the key players?
What is the degree of competition in the South Korea cell therapy market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA CELL THERAPY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA CELL THERAPY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY CELL TYPE
6.1 Stem Cell
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Bone Marrow
6.1.3.2 Blood
6.1.3.3 Umbilical Cord-Derived
6.1.3.4 Adipose-Derived Stem Cell
6.1.3.5 Others
6.1.4 Market Forecast (2026-2034)
6.2 Non-Stem Cell
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY THERAPY TYPE
7.1 Autologous
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Allogeneic
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
8 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY THERAPEUTIC AREA
8.1 Malignancies
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Musculoskeletal Disorders
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Autoimmune Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Dermatology
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
10 SOUTH KOREA CELL THERAPY MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Cell Type
10.1.4 Market Breakup by Therapy Type
10.1.5 Market Breakup by Therapeutic Area
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Cell Type
10.2.4 Market Breakup by Therapy Type
10.2.5 Market Breakup by Therapeutic Area
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Cell Type
10.3.4 Market Breakup by Therapy Type
10.3.5 Market Breakup by Therapeutic Area
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2020-2025)
10.4.3 Market Breakup by Cell Type
10.4.4 Market Breakup by Therapy Type
10.4.5 Market Breakup by Therapeutic Area
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (2026-2034)
10.5 Others
10.5.1 Historical and Current Market Trends (2020-2025)
10.5.2 Market Forecast (2026-2034)
11 SOUTH KOREA CELL THERAPY MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA CELL THERAPY MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA CELL THERAPY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA CELL THERAPY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY CELL TYPE
6.1 Stem Cell
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Bone Marrow
6.1.3.2 Blood
6.1.3.3 Umbilical Cord-Derived
6.1.3.4 Adipose-Derived Stem Cell
6.1.3.5 Others
6.1.4 Market Forecast (2026-2034)
6.2 Non-Stem Cell
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY THERAPY TYPE
7.1 Autologous
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Allogeneic
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
8 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY THERAPEUTIC AREA
8.1 Malignancies
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Musculoskeletal Disorders
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Autoimmune Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Dermatology
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA CELL THERAPY MARKET - BREAKUP BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
10 SOUTH KOREA CELL THERAPY MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Cell Type
10.1.4 Market Breakup by Therapy Type
10.1.5 Market Breakup by Therapeutic Area
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Cell Type
10.2.4 Market Breakup by Therapy Type
10.2.5 Market Breakup by Therapeutic Area
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Cell Type
10.3.4 Market Breakup by Therapy Type
10.3.5 Market Breakup by Therapeutic Area
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2020-2025)
10.4.3 Market Breakup by Cell Type
10.4.4 Market Breakup by Therapy Type
10.4.5 Market Breakup by Therapeutic Area
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (2026-2034)
10.5 Others
10.5.1 Historical and Current Market Trends (2020-2025)
10.5.2 Market Forecast (2026-2034)
11 SOUTH KOREA CELL THERAPY MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA CELL THERAPY MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
